BiotechTube
Home/Kymera Therapeutics/Jared Gollob
JG

Jared Gollob

Chief Medical Officer

Kymera Therapeutics

Therapeutic Areas

ImmunologyOncologyAutoimmune

Kymera Therapeutics Pipeline

DrugIndicationPhase
KT-621Atopic Dermatitis; Other Type 2/Allergic DiseasesPhase 1b
KT-333Peripheral T-cell Lymphoma (PTCL); Cutaneous T-cell Lymphoma (CTCL); Solid TumorsPhase 1a/1b
KT-413Rheumatoid Arthritis & Other Autoimmune IndicationsPreclinical
KT-474Hidradenitis Suppurativa & Atopic DermatitisPhase 2

Leadership Team at Kymera Therapeutics

NM
Nello Mainolfi
Founder, President & CEO
BJ
Bruce Jacobs
Chief Financial Officer
JH
John H. Lee
SVP, Head of Research and Development
RJ
Raymond J. Deshaies
SVP, Global Research (Consultant)
View full Kymera Therapeutics profile